Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182286d41 ◽

2011 ◽

Vol 6 (11) ◽

pp. 1889-1894 ◽

Author(s):

Makoto Nishio ◽

Takeharu Yamanaka ◽

Kazuko Matsumoto ◽

Hideharu Kimura ◽

Kazuko Sakai ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Sulfate Concentration ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Abstract 419: Presence of pulmonary tuberculosis impair survival in advancedEGFRmutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor

10.1158/1538-7445.am2021-419 ◽

2021 ◽

Author(s):

Yalin Xie ◽

Wei Zhou ◽

An Lei ◽

Zhan Huang ◽

Li Weiwei ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Pulmonary Tuberculosis ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Cytoplasmic YAP Expression is Associated with Prolonged Survival in Patients with Lung Adenocarcinomas and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment

Annals of Surgical Oncology ◽

10.1245/s10434-014-3715-5 ◽

2014 ◽

Vol 21 (S4) ◽

pp. 610-618 ◽

Author(s):

Ping-Li Sun ◽

Ji Eun Kim ◽

Seol Bong Yoo ◽

Hyojin Kim ◽

Yan Jin ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Lung Adenocarcinomas ◽

Inhibitor Treatment

Download Full-text

KRASstatus and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis

Colorectal Disease ◽

10.1111/codi.12749 ◽

2014 ◽

Vol 16 (11) ◽

pp. O370-O378 ◽

Author(s):

W. Li ◽

Q. Shi ◽

W. Wang ◽

J. Liu ◽

J. Ren ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2016.79.4.248 ◽

2016 ◽

Vol 79 (4) ◽

pp. 248 ◽

Author(s):

Yoon Soo Chang ◽

Chang-Min Choi ◽

Jae Cheol Lee

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Resistance

Download Full-text

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments

Medicine ◽

10.1097/md.0000000000023150 ◽

2020 ◽

Vol 99 (46) ◽

pp. e23150

Author(s):

Xiayan Zhao ◽

Na Zhang ◽

Haixia Zhang ◽

Ping Liu ◽

Jinan Ma ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Poor Prognosis ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Albumin Ratio ◽

Epidermal Growth

Download Full-text

Chemotherapy should be performed in epidermal growth factor receptor mutation-positive lung adenocarcinoma patients who had progressive disease to the first epidermal growth factor receptor-tyrosine kinase inhibitor

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000917 ◽

2020 ◽

Vol 31 (9) ◽

pp. 959-965

Author(s):

Kosuke Kashiwabara ◽

Shinji Fujii ◽

Shinsuke Tsumura ◽

Kazuhiko Sakamoto

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Progressive Disease ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions

Biomedical Journal ◽

10.1016/j.bj.2015.07.002 ◽

2016 ◽

Vol 39 (2) ◽

pp. 121-129 ◽

Author(s):

Ping-Chih Hsu ◽

Li-Chung Chiu ◽

Shih-Hong Li ◽

Chih-Hung Chen ◽

Chih-Liang Wang ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Survival Benefit ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Primary Lung Adenocarcinoma ◽

Epidermal Growth

Download Full-text

Detection of epidermal growth factor receptor mutation in the peripheral blood of patients with esophageal carcinoma to guide epidermal growth factor receptor-tyrosine kinase inhibitor treatment

Journal of Cancer Research and Therapeutics ◽

10.4103/jcrt.jcrt_735_17 ◽

2018 ◽

Vol 14 (1) ◽

pp. 103 ◽

Author(s):

Hong Lu ◽

Yingjun Xu ◽

Zhihui Xie

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Esophageal Carcinoma ◽

Receptor Tyrosine Kinase ◽

Peripheral Blood ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Placenta‑specific protein 8 promotes the proliferation of lung adenocarcinoma PC‑9 cells and their tolerance to an epidermal growth factor receptor tyrosine kinase inhibitor by activating the ERK signaling pathway

Oncology Letters ◽

10.3892/ol.2019.10911 ◽

2019 ◽

Author(s):

Xiaofei Zeng ◽

Qing Liu ◽

Yanhui Yang ◽

Weikun Jia ◽

Shuping Li ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Specific Protein ◽

Erk Signaling ◽

Epidermal Growth

Download Full-text

Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment

Cancer Science ◽

10.1111/cas.12860 ◽

2016 ◽

Vol 107 (3) ◽

pp. 353-358 ◽

Author(s):

Junji Uchida ◽

Fumio Imamura ◽

Yoji Kukita ◽

Shigeyuki Oba ◽

Toru Kumagai ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Circulating Tumor Dna ◽

Epidermal Growth ◽

Tumor Dna ◽

Inhibitor Treatment

Download Full-text